BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1279155)

  • 1. Demonstration of the receptor-mediated hepatic uptake of dextran in mice.
    Nishikawa M; Yamashita F; Takakura Y; Hashida M; Sezaki H
    J Pharm Pharmacol; 1992 May; 44(5):396-401. PubMed ID: 1279155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties.
    Nishikawa M; Miyazaki C; Yamashita F; Takakura Y; Hashida M
    Am J Physiol; 1995 May; 268(5 Pt 1):G849-56. PubMed ID: 7762669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting.
    Nishikawa M; Kamijo A; Fujita T; Takakura Y; Sezaki H; Hashida M
    Pharm Res; 1993 Sep; 10(9):1253-61. PubMed ID: 7694271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of in vivo fate of albumin derivatives utilizing combined chemical modification.
    Fujita T; Nishikawa M; Ohtsubo Y; Ohno J; Takakura Y; Sezaki H; Hashida M
    J Drug Target; 1994; 2(2):157-65. PubMed ID: 8069594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient scavenger receptor-mediated hepatic targeting of proteins by introduction of negative charges on the proteins by aconitylation: the influence of charge density and size of the proteins molecules.
    Yamasaki Y; Hisazumi J; Yamaoka K; Takakura Y
    Eur J Pharm Sci; 2003 Apr; 18(5):305-12. PubMed ID: 12694882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ selective delivery using a tissue-directed streptavidin--biotin system: targeting 5-fluorouridine via TNP-streptavidin.
    Schechter B; Chen L; Arnon R; Wilchek M
    J Drug Target; 1999; 6(5):337-48. PubMed ID: 10342382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors.
    Yamasaki Y; Sumimoto K; Nishikawa M; Yamashita F; Yamaoka K; Hashida M; Takakura Y
    J Pharmacol Exp Ther; 2002 May; 301(2):467-77. PubMed ID: 11961045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic and Intrahepatic Targeting of Hydrogen Sulfide Prodrug by Bioconjugation.
    Sakai K; Katsumi H; Kamano K; Yamauchi K; Hajima A; Morishita M; Sakane T; Yamamoto A
    Biol Pharm Bull; 2019; 42(2):273-279. PubMed ID: 30713258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver.
    Nishida K; Mihara K; Takino T; Nakane S; Takakura Y; Hashida M; Sezaki H
    Pharm Res; 1991 Apr; 8(4):437-44. PubMed ID: 1714579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic analysis of lectin-dependent biodistribution of fucosylated bovine serum albumin: a possible carrier for Kupffer cells.
    Opanasopit P; Nishikawa M; Yamashita F; Takakura Y; Hashida M
    J Drug Target; 2001; 9(5):341-51. PubMed ID: 11770704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated rat kidney perfused with dextran and bovine serum albumin: a stable model for investigating renal drug handling.
    Wang J; Nation RL; Evans AM; Cox S
    J Pharmacol Toxicol Methods; 2004; 49(2):105-13. PubMed ID: 14990335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and disposition characteristics of recombinant decorin after intravenous injection into mice.
    Masuda H; Takakura Y; Hashida M
    Biochim Biophys Acta; 1999 Feb; 1426(3):420-8. PubMed ID: 10076058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of ischemia/reperfusion injury by hepatic targeting of nitric oxide in mice.
    Katsumi H; Nishikawa M; Yasui H; Yamashita F; Hashida M
    J Control Release; 2009 Nov; 140(1):12-7. PubMed ID: 19646492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design for cell-specific targeting of proteins utilizing sugar-recognition mechanism: effect of molecular weight of proteins on targeting efficiency.
    Nishikawa M; Hirabayashi H; Takakura Y; Hashida M
    Pharm Res; 1995 Feb; 12(2):209-14. PubMed ID: 7784335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate, in the perfused rat liver.
    Sato K; Itakura K; Nishida K; Takakura Y; Hashida M; Sezaki H
    J Pharm Sci; 1989 Jan; 78(1):11-6. PubMed ID: 2468759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake.
    Kawabata K; Takakura Y; Hashida M
    Pharm Res; 1995 Jun; 12(6):825-30. PubMed ID: 7667185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of glutathione-dextran macromolecular conjugate in mice.
    Kaneo Y; Uemura T; Tanaka T; Kanoh S; Matsuoka A
    Biol Pharm Bull; 1995 Nov; 18(11):1544-7. PubMed ID: 8593476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic disposition characteristics of 111In-labeled lactosaminated bovine serum albumin in rats.
    Nishida K; Eguchi Y; Takino T; Takakura Y; Hashida M; Sezaki H
    Pharm Res; 1991 Oct; 8(10):1253-7. PubMed ID: 1796043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition characteristics of macromolecules in tumor-bearing mice.
    Takakura Y; Fujita T; Hashida M; Sezaki H
    Pharm Res; 1990 Apr; 7(4):339-46. PubMed ID: 1694582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition characteristics of glycosylated poly(amino acids) as liver cell-specific drug carrier.
    Akamatsu K; Imai M; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M
    J Drug Target; 1998; 6(3):229-39. PubMed ID: 9888309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.